Study of the Effects of Riboflavin/ Ultraviolet-A Corneal Cross-linking
Study of the Effects of Riboflavin/ Ultraviolet-A Corneal Cross-linking
Recently, riboflavin (0.1%) and ultraviolet-A (UVA) collagen cross-linking (C3R) has shown potential to improve the signs and symptoms of bullous keratopathy .The objective of this study is to demonstrate the effects of C3R to treat bullous keratopathy.
Inclusion Criteria:
Exclusion Criteria: